EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY-NC-ND 4.0

Oral capsules of tetra‐hydro‐cannabinol ( THC ), cannabidiol ( CBD ) and their combination in peripheral neuropathic pain treatment

Kanita Zubcevic, Merete Petersen, Flemming Winther Bach, Aksel Heinesen, Thomas Peter Enggaard, Thomas Peter Almdal, Jakob Vormstrup Holbech, Lene Vase, Troels Stahelin Jensen, Christian Stevns Hansen, Nanna Brix Finnerup, Søren H Sindrup iD

European Journal of Pain · 2023-04 · 27 (4) · 492-506

DOI: 10.1002/ejp.2072 ↗

At a glance

Randomisierte kontrollierte Studie in European Journal of Pain, published online on 2023-01-12. Written by Kanita Zubcevic and 11 co-authors. Institution: Department of Neurology, Odense University Hospital, Odense, Denmark. Major MEDLINE topics: Cannabidiol, Neuralgia. Cited 44 times so far (Crossref); 28 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Ministeriet Sundhed Forebyggelse.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Cannabinoids are often prescribed for neuropathic pain, but the evidence‐based recommendation is ‘weak against’.

Objectives

The aim was to examine the effect of two cannabinoids and their combination in peripheral neuropathic pain.

Methods

This was a randomized, double‐blind, trial with treatment arms for cannabidiol (CBD), tetra‐hydro‐cannabinol (THC), CBD and THC combination (CBD/THC), and placebo in a 1:1:1:1 ratio and flexible drug doses (CBD 5–50 mg, THC 2.5–25 mg, and CBD/THC 5 mg/2.5 mg–50 mg/25 mg). Treatment periods of 8‐week duration were proceeded by 1 week for baseline observations. Patients with painful polyneuropathy, post‐herpetic neuralgia and peripheral nerve injury (traumatic or surgical) failing at least one previous evidence‐based pharmacological treatment were eligible for inclusion. The primary outcome was the change in weekly average of daily pain measured with a numeric rating scale (NRS). Trail Making Test (TMT) was used as one of the tests of mental functioning.

Results

In all, 145 patients were included in the study of which 118 were randomized and 115 included in the intention‐to‐treat analysis. None of the treatments reduced pain compared to placebo ( p = 0.04–0.60). Effect sizes as estimated in week 8 (positive values worse and negative better than placebo) were CBD mean 1.14 NRS points (95% CI 0.11–2.19), THC 0.38 (CI −0.65 to 1.4) and CBD/THC −0.12 (−1.13 to 0.89).

Conclusions

CBD, THC and their combination did not relieve peripheral neuropathic pain in patients failing at least one previous evidence‐based treatment for neuropathic pain.

Subjects

MeSH terms (MEDLINE)

CannabidiolNeuralgiaHumansCannabinolDronabinol

Substances

CannabidiolCannabinolDronabinol

Authors and institutions

  • Department of Neurology, Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Multidisciplinary Pain Center, National Hospital, Copenhagen, Denmark.
  • Department of Neurology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Steno Diabetes Center Copenhagen, Copenhagen, Denmark.

ORCID profiles: Søren H Sindrup

Funding

  • Ministeriet Sundhed Forebyggelse

Cite

APA

Zubcevic, K., Petersen, M., Bach, F. W., Heinesen, A., Enggaard, T. P., Almdal, T. P., Holbech, J. V., Vase, L., Jensen, T. S., Hansen, C. S., Finnerup, N. B., & Sindrup, S. H. (2023). Oral capsules of tetra‐hydro‐cannabinol ( THC ), cannabidiol ( CBD ) and their combination in peripheral neuropathic pain treatment. European Journal of Pain, 27(4), 492-506. https://doi.org/10.1002/ejp.2072

Vancouver

Zubcevic K, Petersen M, Bach FW, Heinesen A, Enggaard TP, Almdal TP, et al. Oral capsules of tetra‐hydro‐cannabinol ( THC ), cannabidiol ( CBD ) and their combination in peripheral neuropathic pain treatment. European Journal of Pain. 2023;27(4):492-506. doi:10.1002/ejp.2072

BibTeX
@article{Zubcevic2023,
  author = {Zubcevic, Kanita and Petersen, Merete and Bach, Flemming Winther and Heinesen, Aksel and Enggaard, Thomas Peter and Almdal, Thomas Peter and Holbech, Jakob Vormstrup and Vase, Lene and Jensen, Troels Stahelin and Hansen, Christian Stevns and Finnerup, Nanna Brix and Sindrup, Søren H},
  title = {Oral capsules of tetra‐hydro‐cannabinol ( THC ), cannabidiol ( CBD ) and their combination in peripheral neuropathic pain treatment},
  journal = {European Journal of Pain},
  year = {2023},
  volume = {27},
  number = {4},
  pages = {492--506},
  doi = {10.1002/ejp.2072}
}
Start for free →